ARGENT CAPITAL MANAGEMENT LLC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 108 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ARGENT CAPITAL MANAGEMENT LLC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2019$3,972,000
-7.2%
188,140
-10.2%
0.15%
-3.8%
Q1 2019$4,281,000
-8.6%
209,550
-11.0%
0.16%
-33.5%
Q4 2018$4,683,000
+3.2%
235,350
-0.2%
0.24%
+51.3%
Q3 2018$4,536,000
+26.1%
235,7750.0%0.16%
+20.0%
Q2 2018$3,598,000
-16.8%
235,775
+2.2%
0.13%
-17.7%
Q1 2018$4,327,000
+1.1%
230,775
+0.5%
0.16%
+6.8%
Q4 2017$4,282,000
+97.6%
229,740
+89.4%
0.15%
+76.2%
Q3 2017$2,167,000
+102.7%
121,275
+102.6%
0.08%
+95.3%
Q2 2017$1,069,00059,8500.04%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2017
NameSharesValueWeighting ↓
LAM GROUP, INC. 128,000$5,886,7205.78%
Beacon Harbor Wealth Advisors, Inc. 103,095$4,7411.58%
Capital Impact Advisors, LLC 15,304$703,8311.18%
Quantedge Capital Pte Ltd 36,389$1,673,5300.91%
Mesirow Institutional Investment Management, Inc. 183,805$8,453,1920.86%
Monashee Investment Management LLC 39,461$1,814,8110.76%
OBERWEIS ASSET MANAGEMENT INC/ 152,500$7,013,4750.74%
Granite Investment Partners, LLC 330,911$15,218,5970.64%
Portolan Capital Management 132,850$6,109,7720.57%
SHAKER INVESTMENTS LLC/OH 20,795$956,3620.53%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders